Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Xianzhou Huang"'
Autor:
Xianzhou Huang, Tao He, Xiuqi Liang, Zhongzheng Xiang, Chao Liu, Shiyao Zhou, Rui Luo, Liping Bai, Xiaorong Kou, Xinchao Li, Rui Wu, Xinyu Gou, Xinyue Wu, Dongxue Huang, Wangxian Fu, Yingjie Li, Ruhan Chen, Ningyue Xu, Yixi Wang, Hao Le, Tao Chen, Yangsong Xu, Yuting Tang, Changyang Gong
Publikováno v:
MedComm – Oncology, Vol 3, Iss 1, Pp n/a-n/a (2024)
Abstract Rapid growth in nanoparticles (NPs) as delivery systems holds vast promise to promote therapeutic approaches for cancer treatment. Presently, a diverse array of NPs with unique properties have been developed to overcome different challenges
Externí odkaz:
https://doaj.org/article/34ffa542c8ff4e709136348e7e9cae10
Autor:
Xianzhou Huang, Lu Li, Chunqing Ou, Meiling Shen, Xinchao Li, Miaomiao Zhang, Rui Wu, Xiaorong Kou, Ling Gao, Furong Liu, Rui Luo, Qinjie Wu, Changyang Gong
Publikováno v:
Advanced Science, Vol 10, Iss 35, Pp n/a-n/a (2023)
Abstract Coevolution of tumor cells and surrounding stroma results in protective protumoral environment, in which abundant vessel, stiff structure and immunosuppression promote each other, cooperatively incurring deterioration and treatment compromis
Externí odkaz:
https://doaj.org/article/1158966ec4b042bf87ca4f8b87c704ad
Autor:
Xianzhou Huang, Haijun Li, Chunqing Ou, Yaqian Shu, Rui Luo, Xinchao Li, Shouchun Chen, Qinjie Wu, Changyang Gong, Lei Liu
Publikováno v:
Materials & Design, Vol 211, Iss , Pp 110137- (2021)
Pancreatic cancer generates resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by downregulating death receptors and switching pro-apoptosis to anti-apoptosis through caspases blockers like X-linked inhibitor of apoptosis p
Externí odkaz:
https://doaj.org/article/b2783e287b65449eae7739e0da2fc6a9
Autor:
Furong Liu, Tao He, Songlin Gong, Meiling Shen, Shuang Ma, Xianzhou Huang, Lu Li, Li Wang, Qinjie Wu, Changyang Gong
Publikováno v:
Acta Biomaterialia. 154:510-522
Autor:
Yan Wang, Xianzhou Huang, Shunyao Zhu, Lu Li, Jin Yang, Jie Li, Li Wang, Shuang Ma, Meiling Shen, Qinjie Wu, Changyang Gong
Publikováno v:
Chemical Engineering Journal. 461:141816
Autor:
Furong Liu, Songlin Gong, Tao He, Meiling Shen, Shuang Ma, Xianzhou Huang, Lu Li, Li Wang, Qinjie Wu, Changyang Gong
Publikováno v:
SSRN Electronic Journal.
Autor:
Lu Li, Xiuqi Liang, Tao He, Xinchao Li, Xianzhou Huang, Ning Wang, Meiling Shen, Yaqian Shu, Rui Wu, Miaomiao Zhang, Qinjie Wu, Changyang Gong
Publikováno v:
Biomaterials. 290:121815
Photothermal therapy (PTT) has been known as an effective weapon against cancer. However, the necrosis induced by hyperthermia post PTT can trigger excessive inflammation response and arouse tumor self-protection resulting in tumor immunosuppression,
Autor:
Yongmei Xie, Xianzhou Huang, Yaqian Shu, Yinchen Lin, Qinjie Wu, Mingxing Hu, Anqi Zeng, Linjiang Song, Changyang Gong
Publikováno v:
Journal of Biomedical Nanotechnology. 14:267-280
7-Ethyl-10-hydroxy-camptothecin (SN-38), an efficient topoisomerase inhibitor, is the biological metabolite of irinotecan used as the first-line chemotherapy drug for colon cancer. However, the hydrophobicity and instability of SN-38 limit its furthe
Autor:
Lei Liu, Rui Luo, Qinjie Wu, Xianzhou Huang, Yaqian Shu, Shouchun Chen, Haijun Li, Xinchao Li, Chunqing Ou, Changyang Gong
Publikováno v:
Materials & Design, Vol 211, Iss, Pp 110137-(2021)
Pancreatic cancer generates resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by downregulating death receptors and switching pro-apoptosis to anti-apoptosis through caspases blockers like X-linked inhibitor of apoptosis p
Autor:
Yan Wang, Yaqian Shu, Changyang Gong, Shouchun Chen, Qinjie Wu, Xianzhou Huang, Songlin Gong, Chunqing Ou, Rui Luo
Publikováno v:
Biomaterials. 272:120795
Since the 5-year survival rate of pancreatic cancer is only 10.0%, new therapies are urgently needed. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis specifically on tumor cells, nevertheless its clinical application